ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 29 filers reported holding ACER THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $42,000 | – | 1,365 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nantahala Capital Management | 1,136,416 | $1,049,367 | 0.10% |
| Anson Funds Management LP | 129,795 | $119,853 | 0.02% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 60,000 | $55 | 0.01% |
| Hudson Bay Capital Management LP | 274,300 | $253,289 | 0.00% |
| UBS Group AG | 33 | $30 | 0.00% |
| RHUMBLINE ADVISERS | 347 | $320 | 0.00% |
| OSAIC HOLDINGS, INC. | 200 | $184 | 0.00% |
| WELLS FARGO & COMPANY/MN | 132 | $122 | 0.00% |
| NORTHERN TRUST CORP | 22,231 | $20,528 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |